High-intensity Focused Ultrasound Study
Lay title: An Observational Study to Learn More About Using High-Intensity Focused Ultrasound for the Removal of Prostate Tissue
Technical title: High-Intensity Focused Ultrasound for Focal Ablation of Prostate Tissue: An Observational Study of Multiparametric MRI and Ultrasound Fusion Imaging for Guidance
Disease Type:Prostate Cancer
Basic Information:The purpose of this observational research study is to collect and analyze clinical data from patients before and after receiving HIFU (High Intensity Focused Ultrasound). HIFU is an FDA-approved tool used to ablate prostate tissue. The Sonablate HIFU device was approved by the U.S. FDA for prostate tissue ablation in October, 2015.
Research Procedures (not a complete list): Upon obtaining subjects’ informed consent to participate in the study, they will agree to the collection of clinical data for research purposes, and be asked to complete optional pre- and post-treatment questionnaires about quality-of-life data and decision-making.
Eligibility Criteria (not a complete list):
For More Detailed Information, Contact: